How a leading chronic disease management and prevention platform is disrupting the diabetes space – Interview with Cameron Jacox, Vice President of Growth at Lark Health
There are hundreds of millions of patients globally suffering from chronic diseases with millions having prediabetes and just a small percent of those being aware of their health condition. According to the Centers for Disease Control and Prevention, just within the USA, six in ten Americans live with at least one chronic disease and 90% Learn more...
Are digital preventive services in healthcare ready to take off? R2G just launched a global digital health survey to find out.
R2G just launched a new survey targeting the topic of digital prevention services in health and most specifically in diabetes prevention. To have a better understanding of these current trends, the survey explores the potential market readiness both from the payer’s perspective as well as from digital health providers. Also, the survey aims to understand Learn more...
Disruption in Healthcare – What will be the new normal?
Allow me to raise this question: what will happen to a pharma company’s diabetes, respiratory or cardiology drugs if in 10 years time, we are able to fully use 3D organ printing?Well, it would most likely disrupt its traditional business models of selling drugs for those diseases, wouldn’t it? It seems that there is hardly Learn more...
Food tracking: How do apps know what is on the plate. Four strategies to overcome tech limitations
Tracking food habits is a growing market, with hundreds of available food apps, the competition is high, and technology is trying to keep up with the demand. Given the complexity of this task, new strategies have risen, and consumers have been offered innovative approaches to track their food habits.Which are the current technologies being used Learn more...
Digital Health in Germany and The Netherlands – Oranje Boven? – Interview with Jan-Eric Slot
The Netherlands are always referred to as one of the leading nations in Europe and even worldwide, when it comes to Digital Health. An attribute and quality that is not necessarily associated with the German healthcare system. We wanted to know whether this is really true and what the reasons are for the country’s exceptional Learn more...
Lessons learned from Onelife Health’s founder about how to do the go-to-market in the women’s digital healthcare market: Interview with David Schaerf
As the leading analyst and strategy consulting company for the digital health market, we have been exploring the developments of digital health and the way new technologies disrupt and reshape different market segments such as diabetes, respiratory, health insurance since 2010. Our new market study is concentrated on sizing the global women’s digital healthcare market, Learn more...
The changing business environment for digital health accelerators – are the heydays over?
The growth rate for new digital health accelerators has significantly slowed down over the last 2 years. At the same time, it is getting more and more difficult for many accelerators to fill their portfolios with good quality start-ups. With a little more than 350 digital health accelerators currently existing, and around 15,000 health app Learn more...
Why pharma should invest in digitally-enabled and patient-centric business models
Pharma has a productivity, regulatory and business challenge at hand in terms of bringing new drugs and therapies to the market and catering for the emerging needs of patient-centric care. How can pharma address and cope with this challenge? Patient-centered digital apps and solutions are able to provide a brand new arsenal of possibilities to Learn more...
What hinders the digitalization of chronic conditions: ten major barriers and possible solutions
Hundreds of millions of patients are affected by chronic diseases globally, often suffering from several of them. Despite such a huge opportunity, the coverage of chronic conditions with digital solutions is still below the acceptable level. Each of more than twenty common chronic conditions has its own specificity and is currently at its digital development Learn more...